
About H2OPTX
H2OPTX is a company based in San Jose (United States) founded in 2012. H2OPTX operates in a competitive market with competitors including Bruker, Asimov, Cellarity, Metrohm and Metaphore, among others.
- Headquarter San Jose, United States
- SectorsHealthcareTechnology
- Website h2optx.com
- Social LinkedIn Facebook
- Latest Funding Round$65.29K (USD), Grant
Sep 2017
- Investors
Funding Insights of H2OPTX
- Total Rounds 1
- Last Round Grant β $65,290
- First Round $65,290
(Sep 2017)
- Investors Count 1
All 1 funding rounds of H2OPTX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2017 | $65,290 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in H2OPTX
H2OPTX has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for H2OPTX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of H2OPTX
2 dated milestones of H2OPTX across 5 years, from founding to its latest funding, stage changes and deals.
- Founded H2OPTX is founded.
- Funding First funding round of $65K.
Competitors of H2OPTX
H2OPTX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bruker, Asimov, Cellarity, Metrohm and Metaphore, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bruker.com | 1960 | United States | – | 9,707 | Diversified research instrument systems are manufactured and supplied. | |
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| cellarity.com | 2015 | Cambridge, United States | $294M | 117 | Developer of drugs to treat various diseases | |
| metrohm.com | 1943 | Herisau, Switzerland | – | 608 | Instruments for chemical analysis are developed and manufactured. | |
| metaphorebio.com | 2021 | Cambridge, United States | $50M | – | Provider of machine language and computational platform for drug discovery | |
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. | |
| panakeia.ai | 2018 | London, United Kingdom | $3.79M | 12 | AI-based software is provided for cancer diagnosis and precision treatment. | |
| evolvedbynature.com | 2013 | Medford, United States | $190M | 99 | Digital technology for biomedicinal molecule development in research is utilized. | |
| algorithmicbiologics.com | 2021 | Bengaluru, India | $2.84M | – | Provider of software solutions for molecular diagnostics and discovery | |
| speclipse.com | 2015 | Seongnam-si, South Korea | $10.55M | – | Molecular spectroscopy systems for early skin cancer detection are provided. |
Detailed competitors of H2OPTX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to H2OPTX
10 companies that operate in the same segment as H2OPTX (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about H2OPTX
H2OPTX was founded in 2012 and raised its 1st funding round 5 years after it was founded.
H2OPTX is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Founded in 2012 and based in San Jose, United States, H2OPTX operates in the pharmaceuticals sector. Solutions integrating Raman spectroscopy, optical, and UV microscopy are developed for analyzing chemical structures. Tablets and large volumes of complex powders are scanned using automated X-Y-Z surface methods. Software for processing multi-spectral data from the H2Optx mPAT LAB system is offered, along with RD and IP development services.
H2OPTX has 1 investor. Key investors include HHS.